Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;9(1):108-12.
doi: 10.1093/ckj/sfv120. Epub 2015 Nov 20.

Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series

Domenico Russo  1 , Alfredo Capuano  1 , Mario Cozzolino  2 , Paola Napolitano  1 , Francesca Mosella  3 , Luigi Russo  4 , Caterina Saviano  5 , Carmine Zoccali  6
Affiliations

Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series

Domenico Russo et al. Clin Kidney J. 2016 Feb.

Abstract

Background: This is an incident series of five dialysis patients with late-diagnosed calcific uraemic arteriolophathy (CUA), severe uncontrolled hyperparathyroidism and infected skin ulcerations.

Methods: A multimodal intervention was based on wound care, antibiotics, surgical debridement, sodium thiosulphate and cinacalcet and associated with regression of skin disease in four cases after varying treatment time periods ranging from 4 to 33 months.

Results: Multimodal treatment including sodium thiosulphate and cinacalcet was associated with very favourable local outcomes and survival. This series further confirms that the diagnosis of CUA is rarely made at the nodular, non-ulcerative phase of the disease.

Conclusions: This series contributes to the build-up of case series reporting on the treatment of CUA, and will hopefully serve as a basis of well-conceived comparative effectiveness studies investigating the value of the combined interventions applied so far in this severe condition.

Keywords: CUA; calcific uraemic arteriolopathy; cinacalcet; parathyroid hormone; skin ulcers.

PubMed Disclaimer

References

    1. Schlieper G, Schurgers L, Brandenburg V, et al. Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant 2015; 1–9 - PubMed
    1. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002; 61: 2210–2217 - PubMed
    1. Brandenburg VM, Sinha S, Specht P, et al. Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder. Pediatr Nephrol 2014; 29: 2289–2298 - PubMed
    1. Santos PW, Hartle SE, Quarles LD. Calciphylaxis (calciphyc uremic arteriolopathy). 2015. http://www.uptodate.com/contents/calciphylaxiscalcificuremicarteriolopathy (30 October 2015, date last accessed)
    1. Bolignano D, Nagler EV, Van BW, et al. Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence. Nephrol Dial Transplant 2014; 29: 1628–1632 - PubMed

LinkOut - more resources